Enhanced activity of HIV vaccine using a second generation immunomodulatory oligonucleotide

Fc fusion proteins for enhancing the immunogenicity of protein and peptide antigens

Carbohydrate-based synthetic vaccines for HIV

Mucosal cytotoxic T lymphocyte responses

Compositions and methods to initiate or enhance antibody and major-histocompatibility class I or class II-restricted t cell responses by using immunomodulatory, non-coding rna motifs

Methods of delivery of exogenous proteins to the cytosol and uses thereof

Polynucleotides encoding antigenic HIV type B polypeptides, polypeptides and uses thereof

Microparticles with adsorbent surfaces, methods of making same, and uses thereof

Preventive and therapeutic aids vaccines

Immuno-modulating effects of chemokines in DNA vaccination

Microparticles with adsorbent surfaces, methods of making same, and uses thereof

Albumin fusion proteins comprising GLP-1 polypeptides

Human immunodeficiency virus-neutralizing human antibodies with improved breadth and potency

Use of microparticles combined with submicron oil-in-water emulsions

Synthetic peptide vaccines for HIV: the CBD epitope as an effective immunogen to elicit broadly neutralizing antibodies against HIV

Alphavirus vectors and virosomes with modified HIV genes for use as vaccines

Pharmaceutical composition for immunization against AIDS

Compositions of protein mimetics and methods of using same against HIV-1, SARS-coV and the like

Aids vaccines

Hiv-1 envelope glycoproteins stabilized by flexible linkers as potent entry inhibitors and immunogens

Method of inducing an enhanced immune response against hiv

Human immunodeficiency virus envelope clycoprotein mutants and uses thereof

Pseudomonas exotoxin A-like chimeric immunogens for eliciting a secretory IgA-mediated immune response

Enhanced first generation adenovirus vaccines expressing codon optimized HIV1-Gag, Pol, Nef and modifications

Compositions, method and kits relating to deletion mutations of immunodeficiency virus gp120 hypervariable regions

Vaccine comprising gp120 and nef and/or tat for the immunisation against hiv

Polynucleotide encoding a mutated HIV gp41 polypeptide

Recombinant negative strand RNA virus expression systems and vaccines

Materials and methods for immunizing against FIV infection

HIV-1 envelope glycoproteins having unusual disulfide structure

Particle-mediated delivery of antigens

Extreme polyvalency induces potent cross-clade cellular and humoral responses in rabbits and non-human primates